AirSculpt Technologies, which provides minimally-invasive body contouring procedures in the US, raised $77 million by offering 7 million shares at $11, the low end of the range of $11 to $12. The company originally filed to raise $160 million by offering 10 million shares at range of $15 to $17 per share. At pricing, the company commands a market value of $612 million.
Operating as Elite Body Sculpture, the company provides custom body contouring using its proprietary AirSculpt method, and performed over 5,800 body contouring procedures in 2020. The company delivers its body contouring procedures through a growing footprint of 16 centers across 13 states as of October 5, 2021.
AirSculpt Technologies plans to list on the Nasdaq under the symbol AIRS. Morgan Stanley, Piper Sandler, and SVB Leerink acted as lead managers on the deal.
